78471-43-9

Basic information

• Product Name: METHYL 4-BROMO-2-BROMOMETHYL-BENZOATE
• Synonyms: METHYL 4-BROMO-2-BROMOMETHYL-BENZOATE;1-(4-BROMO-2-(BROMOMETHYL)PHENYL)ETHANONE;4-BroMo-2-broMoMethyl-benzoic acid Methyl ester;Benzoic acid, 4-broMo-2-(broMoMethyl)-, Methyl ester;Methyl 2-bromomethyl-4-bromobenzoate
• CAS NO: 78471-43-9
• Molecular Formula: C₉H₈Br₂O₂
• Molecular Weight: 307.97
• Mol File: 78471-43-9.mol
• Article Data: 62

Chemical Properties

• Melting Point: 76-78℃
• Boiling Point: 364.267 °C at 760 mmHg
• Flash Point: 174.103 °C
• Appearance: /
• Density: 1.78 g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• Water Solubility: Slightly soluble in water.
• CAS DataBase Reference: METHYL 4-BROMO-2-BROMOMETHYL-BENZOATE(CAS DataBase Reference)
• NIST Chemistry Reference: METHYL 4-BROMO-2-BROMOMETHYL-BENZOATE(78471-43-9)
• EPA Substance Registry System: METHYL 4-BROMO-2-BROMOMETHYL-BENZOATE(78471-43-9)

Safety Data

• RIDADR: UN 3261 8/PG III
• HazardClass: 8
• PackingGroup: III
• Hazardous Substances Data: 78471-43-9(Hazardous Substances Data)

Usage

Uses

Methyl 4-bromo-2-(bromomethyl)benzoate is used as pharmaceutical intermediate.

InChI:InChI=1/C9H8Br2O2/c1-13-9(12)8-3-2-7(11)4-6(8)5-10/h2-4H,5H2,1H3

Upstream product

• 99548-55-7 4-bromo-2-methyl-benzoic acid methyl ester 
• 7440-33-7 tungsten 
• 67-56-1 methanol 
• 68837-59-2 4-bromo-2-methylbenzoic acid 

Downstream Products

• 474711-28-9 5-bromo-2-(4-fluorobenzyl)-2,3-dihydroisoindol-1-one 
• 552330-86-6 5-bromoisoindolin-1-one 
• 477716-92-0 methyl 2-(5-bromo-1-oxoisoindolin-2-yl)-2-phenyl acetate 
• 864866-47-7 5-bromo-2-(propan-2-yl)-2,3-dihydro-1H-isoindol-1-one 
• 1132943-32-8 5-bromo-2-(2,4-dimethoxybenzyl)isoindolin-1-one 
• 1202236-43-8 C₂₆H₂₂N₂O₄ 
• 1202236-59-6 C₂₆H₂₂N₂O₄ 
• 1131217-28-1 4-(2-{2-[(2R)-2-methylpyrrolidin-1-yl]ethyl}-1-oxo-2,3-dihydro-1H-isoindol-5-yl)benzonitrile hydrochloride 
• 864867-11-8 5-bromo-2-cyclopentyl-2,3-dihydro-1H-isoindol-1-one 
• 1430058-49-3 5-bromo-2-((1S)-2-hydroxy-1-{3-[(trimethylsilyl)ethynyl]benzyl}ethyl)isoindolin-1-one 
• 1430058-94-8 2-[(2S)-2-(5-bromo-1-oxo-1,3-dihydro-2H-isoindol-2-yl)-3-cyclohexylpropyl]-1H-isoindole-1,3(2H)-dione 

Relevant articles and documents

Discovery and biological profile of isoindolinone derivatives as novel metabotropic glutamate receptor 1 antagonists: A potential treatment for psychotic disorders

We describe here the discovery and biological profile of a series of isoindolinone derivatives as developed mGluR1 antagonists. Our combined strategy of rapid parallel synthesis and conventional medicinal optimization successfully led to N-cyclopropyl 22 and N-isopropyl isoindolinone analogs 21 and 23 with improved in vivo DMPK profiles. Moreover the most advanced analog 23 showed an oral antipsychotic-like effect at a dose of 1 mg/kg in an animal model.

PROCESSES FOR PREPARING 2-(4-CHLOROPHENYL)-N-((2-(2,6-DIOXOPIPERIDIN-3-YL)-1-OXOISOINDOLIN-5-YL)METHYL)-2,2-DIFLUOROACETAMIDE

Provided herein are processes for preparing 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide.

Aminopyrazine/pyridine compound and preparation method and application thereof

The invention discloses an aminopyrazine/pyridine compound and a preparation method and application thereof. Particularly, a pyrazine/pyridylamine compound shown as a general formula I, or pharmaceutically acceptable salt thereof, or enantiomer, diastereoisomer, tautomer, solvate, polymorphic substance or prodrug thereof, a preparation method thereof and application in pharmacy are disclosed, andthe definition of each group is shown in the specification.